The 5 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +181.86% increase from the last price of 4.08.
The current consensus among 5 polled investment analysts is to Buy stock in Interpace Biosciences Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.30
Reporting Date Nov 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.